Subscribe
22 September 2017Americas

Video interview: Allen & Overy on CRISPR evolution

To evaluate how the CRISPR licensing landscape might evolve, parties need to analyse the current patent environment.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Video interview: Allen & Overy on the UPC and CRISPR
19 September 2017   The Unified Patent Court is likely to spark years of uncertainty and may even become part of the UK’s negotiations for Brexit.
article
Video interview: Canada prepares for PTE system
5 September 2017   The development of Canada’s exclusivity framework was the focus of a roundtable at Life Sciences Patent Network North America, hosted by LSPR in Boston.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

More on this story

Americas
Video interview: Allen & Overy on the UPC and CRISPR
19 September 2017   The Unified Patent Court is likely to spark years of uncertainty and may even become part of the UK’s negotiations for Brexit.
article
Video interview: Canada prepares for PTE system
5 September 2017   The development of Canada’s exclusivity framework was the focus of a roundtable at Life Sciences Patent Network North America, hosted by LSPR in Boston.

More on this story

Americas
Video interview: Allen & Overy on the UPC and CRISPR
19 September 2017   The Unified Patent Court is likely to spark years of uncertainty and may even become part of the UK’s negotiations for Brexit.
article
Video interview: Canada prepares for PTE system
5 September 2017   The development of Canada’s exclusivity framework was the focus of a roundtable at Life Sciences Patent Network North America, hosted by LSPR in Boston.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB